In an MC38 xenograft C57BL/6 model [133], CBD reprogramed the metabolic process of macrophages, inhibited PI3K-Akt signaling, shaped the tumor microenvironment, and enhanced the response to anti-PD-1 immunotherapy to prevent tumor progression. Here, AKT1 is linked to neoplasm.